[1]OTT JJ, STEVWNS GA, GROEGER J, et al. Global epidemiology of hepatitis B virus infection:New estimates of age-specific HBsAg seroprevalence and endemicity[J]. Vaccine, 2012, 30 (12) :2212-2219.
|
[2]LU FM, ZHUANG H. Management of hepatitis B in China[J].Chin Med J (Engl) , 2009, 122 (1) :3-4.
|
[3]WANG FS, FAN JG, ZHANG Z, et al. The global burden of liver disease:The major impact of China[J]. Hepatology, 2014, 60 (6) :2099-2108.
|
[4]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention andtreatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
[5]YU HB, ZHAI Y, SUN YN, et al. Clinical characteristics of HBe Ag positive and HBe Ag negative chronic hepatitis B[J].Chin Clin Dr, 2017, 45 (2) :35-38. (in Chinese) 于海滨, 翟云, 孙亚男, 等. HBe Ag阴性及HBe Ag阳性慢性乙型肝炎患者的临床特征比较[J].中国临床医生杂志, 2017, 45 (2) :35-38.
|
[6]LI W, CHEN G, YU X, et al. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China[J]. Int J Clin Exp Pathol, 2013, 6 (6) :1076-1085.
|
[7]LYU H, LEE D, CHUNG YH, et al. Synergistic effects of Al896, T1653 and T1762/A l764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma[J]. J Viral Hepat, 2013, 20 (3) :219-224.
|
[8]GAO SX. The research progress of hepatitis B virus e antigen[J]. Med Recapitulate, 2011, 17 (14) :2151-2153. (in Chinese) 高尚秀.乙型肝炎病毒e抗原的研究进展[J].医学综述, 2011, 17 (14) :2151-2153.
|
[9]OKAMOTO H, TSUDA F, AKAHANE Y. Hepatitis B virus with mutations in the e antigen-negative phenotype in carriers with e antibody to e antigen[J]. Virol, 1994, 68 (12) :8102-8110.
|
[10]ALESTIG E, HANNOUN C, HORAL P, et al. Phylogenetic origin of hepatitis B virus strains with precore-1858 variant[J].J Clin Microbiol, 2001, 39 (9) :3200-3203.
|
[11]LUO KX. Hepatitis B basic biology and clinical science[M].Beijing:People’s Medical Publishing House, 2006:56-57. (in Chinese) 骆抗先.乙型肝炎基础和临床[M].北京:人民卫生出版社, 2006:56-57.
|
[12]LI JE, CHEN XY. Recent progress in research of hepatitis B viruses with precore and basic core promoter mutations[J]. J Clin Hepatol, 2013, 29 (2) :88-92. (in Chinese) 李金娥, 陈新月.乙型肝炎病毒前C/BCP区变异的研究现状[J].临床肝胆病杂志, 2013, 29 (2) :88-92.
|
[13]CUI XJ, CHO YK, SONG BC. Influence of the basal core promoter and precore mutation on replication of hepatitis B virus and antiviral susceptibility of different genotypes[J]. J Med Virol, 2015, 87 (4) :601-608.
|
[14]LIN CL, KAO JH. Hepatitis B virus genotypes and variants[J].Cold Spring Harb Perspect Med, 2015, 5 (5) :a021436.
|
[15]ALEXOPOLOU A, KARAYIANNIS P. HBe Ag negative variants and their role in the natural history of chronic hepatitis B virus infection[J]. World J Gastroenterol, 2014, 20 (24) :7644-7652.
|
[16]HUSSAIN Z, JUNG HS, RYU DK, et al. Genetic dissection of naturally occurring basal core promoter mutations of hepatitis B virus reveals a silent phenotype in the overlapping X gene[J].J Gen Virol, 2009, 90 (9) :2272-2281.
|
[17]TONG MJ, PAN CQ, HARM HW, et al. The management of chronic hepatitis B in Asian Americans[J]. Dig Dis Sci, 2011, 56 (11) :3143-3162.
|
[18]ZONG L, QIN Y, JIA H, et al. Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region[J]. Virology, 2017, 505 (5) :155-161.
|
[19]XU YJ, SONG WQ. Association of mutations in basal core promoter and precore region of hepatitis B virus with progress of liver disease[J]. Chin J Clin Infect Dis, 2012, 5 (4) :253-256. (in Chinese) 徐尧江, 宋伟泉. HBV基本核心启动子区和前C区变异与肝病进展的关系[J].中华临床感染病杂志, 2012, 5 (4) :253-256.
|
[20]ZHOU WH, DING SX, WENG PJ. Effects of HBV pre-core and basal core promoter mutations on serum HBV DNA level in chronic hepatitis B using Gene-chip technique[J]. J Chin Physic, 2006, 8 (3) :350-352. (in Chinese) 周文红, 丁世雄, 翁彭剑.乙型肝炎病毒前C区/BCP区突变对血清HBV DNA含量的影响[J].中国医师杂志, 2006, 8 (3) :350-352.
|
[21]SUN M, CHEN QZ, ZHAO HJ, et al. Clinical significance of PC/BCP region variation and the serum parameters in HBV chronic infection patients[J]. Chin Trop Med, 2017, 17 (9) :912-914, 924. (in Chinese) 孙敏, 陈巧真, 赵华菊, 等. HBV慢性感染者PC/BCP区变异特点及血清检测指标临床意义[J].中国热带医学, 2017, 17 (9) :912-914, 924.
|
[22]WANG XL, REN JP, WANG XQ, et al. Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients[J]. World J Gastroenterol, 2016, 22 (11) :3268-3274.
|
[23]DENG YJ, QIAN J. Pre-C/basic core promoter gene mutation in chronic HBV infection and its clinical application[J].Chin J Integr Tradit West Med Liver Dis, 2015, 25 (4) :239-241. (in Chinese) 邓拥军, 钱军.慢性HBV感染者HBV前C区/基本核心启动子区基因突变与临床应用[J].中西医结合肝病杂志, 2015, 25 (4) :239-241.
|
[24]CHACHA SGF, GOMES-GOUVEA MS, MALTA FM, et al.Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseases[J]. Mem Inst Oswaldo Cruz, 2017, 112 (9) :626-631.
|
[25]ZHOU H, GEWAILY D, AHN SH, et al. Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer[J]. Virus Res, 2017, 235:86-95.
|
[26]PARK YM, JANG JW, YOO SH, et al. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma[J]. J Viral Hepat, 2014, 21 (3) :171-177.
|
[27]WEI F, ZHENG Q, LI M, et al. The association between hepatitis B mutants and hepatocellular carcinoma:A meta-analysis[J]. Medicine (Baltimore) , 2017, 96 (19) :e6835.
|
[28]MALIK A, SINGHAL DK, ALBANYAN A. Hepatitis B virus gene mutations in liver diseases:A report from New Delhi[J]. PLo S One, 2012, 7 (6) :e39028.
|
[29]WANG M, HU YF, SHI WT, et al. Associations between hepatitis B virus X gene mutations and hepatocellular carcinoma[J]. Chin J Hepatol, 2015, 23 (8) :599-603. (in Chinese) 王淼, 胡艳芳, 史为涛, 等.原发性肝细胞癌患者乙型肝炎病毒X基因突变检测及其临床意义[J].中华肝脏病杂志, 2015, 23 (8) :599-603.
|
[30]CHEN F, LI CS. Relationship between HBV base core promoter and precore mutation with hepatocellular carcinoma in HBe Ag negative patients[J]. Jiangsu Med J, 2017, 43 (6) :418-421. (in Chinese) 陈飞, 李传生. HBV基本核心启动子区和前C区变异与HBe Ag阴性患者肝癌发生的关系[J].江苏医药, 2017, 43 (6) :418-421.
|
[31]ELIZALDE MM, SEVIC I, GONZLEZ LPEZ LEDESMA MM, et al. Human hepatocytes apoptosis induced by replication of hepatitis B virus subgenotypes F1b and F4:Role of basal core promoter and preCore mutations[J]. Virology, 2018, 513 (1) :160-167.
|
[32] HAN YP, LI J, JIANG LF, et al. Hepatitis B e antigen from chronic hepatitis B patients induces Th1/Th2 cytokine imbalance in vitro[J]. Chin J Hepatol, 2013, 21 (8) :584-589. (in Chinese) 韩亚萍, 李军, 蒋龙凤, 等. HBe Ag导致慢性乙型肝炎患者外周血Th1/Th2型细胞因子失衡[J].中华肝脏病杂志, 2013, 21 (8) :584-589.
|
[33]JIANG XH, LI XF. The relationship between HBV precore and basal core promoter mutations and serum cytokines in patients with chronic hepatitis B[J]. Chin J Infect Control, 2010, 9 (5) :320-323. (in Chinese) 蒋孝华, 李小芬.慢性乙型肝炎患者HBV前C区及BCP区变异与血清细胞因子的关系[J].中国感染控制杂志, 2010, 9 (5) :320-323.
|
[34] GUO W. A study on Hepatitis B virus BCP/Pre-C gene mutations and Th1/Th2 immunological condition in Patients with chronic severe hepatitis B[D]. Wuhan:Huazhong University of Science and Technology, 2006:1-74. (in Chinese) 郭威.慢性重型乙型肝炎患者HBV BCP/前C区基因变异及Th1/Th2免疫状态的研究[D].武汉:华中科技大学, 2006:1-74.
|
[35]GAO HB, WANG XM, LIU BR, et al. Expression of Treg and Th17in HBV-related acute-on-chronic liver failure patients and their correlations with the mutations in HBV pre-C/BCP region[J].Chin Hepatol, 2018, 23 (1) :18-21, 86. (in Chinese) 高海兵, 王香梅, 刘宝荣, 等. HBV相关慢加急性肝衰竭患者Treg细胞、Th17细胞表达特点及其与HBV前C区/BCP区变异的相关性[J].肝脏, 2018, 23 (1) :18-21, 86.
|
[36]YANG S, XING HC, CHENG J. Progress in hepatitis B virus resistance to nucleos (t) ide analogues[J/CD]. Chin J Exp Clin Infect Dis:Electronic Edition, 2018, 12 (1) :1-6. (in Chinese) 杨松, 邢卉春, 成军.乙型肝炎病毒核苷 (酸) 类似物耐药研究进展[J/CD].中华实验和临床感染病杂志:电子版, 2018, 12 (1) :1-6.
|
[37]SONG BC, CUI XJ, SHIN JW, et al. Response to adefovir depends on mutation patterns in precore region, basal core promoter and reverse transcriptase, and on-treatment responses in Lamivudine-resistant chronic hepatitis B patients[J].Intervirology, 2010, 53 (4) :203-210.
|
[38]BELYHUN Y, LIEBERT UG, MAIE M. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia[J]. PLo S One, 2018, 13 (2) :e0191970.
|